{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:52:31Z","timestamp":1778064751877,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jfo.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T18:37:31Z","timestamp":1545071851000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9718-7307","authenticated-orcid":false,"given":"B.","family":"Cochener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Zagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hugny-Larroque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Derrien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2018.05.009_bib0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.sjopt.2014.06.011","article-title":"Management strategies for persistent epithelial defects of the cornea","volume":"28","author":"Katzman","year":"2014","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jfo.2018.05.009_bib0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2147\/OPTH.S81061","article-title":"A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)","volume":"9","author":"Aslanides","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2018.05.009_bib0110","first-page":"571","article-title":"Diagnosis and management of neurotrophic keratitis","volume":"8","author":"Sacchetti","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2018.05.009_bib0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10719-016-9744-5","article-title":"RGTA\u00ae or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients","volume":"34","author":"Barritault","year":"2017","journal-title":"Glycoconj J"},{"key":"10.1016\/j.jfo.2018.05.009_bib0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jbspin.2016.06.012","article-title":"RGTA\u00ae-based matrix therapy \u2013 a new branch of regenerative medicine in locomotion","volume":"84","author":"Barritault","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jfo.2018.05.009_bib0125","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1167\/iovs.04-1368","article-title":"Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury","volume":"46","author":"Sosne","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2018.05.009_bib0130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.exer.2013.07.001","article-title":"A synthetic connexin 43 mimetic peptide augments corneal wound healing","volume":"115","author":"Moore","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2018.05.009_bib0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jfo.2013.01.012","article-title":"RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies","volume":"36","author":"Brignole-Baudouin","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2018.05.009_bib0140","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1167\/iovs.12-10476","article-title":"Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers","volume":"53","author":"Aifa","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2018.05.009_bib0145","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/ICO.0000000000000169","article-title":"Combined topical application of a regenerative agent with a bandage contact lens for the treatment of persistent epithelial defects","volume":"33","author":"Kymionis","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2018.05.009_bib0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/ICO.0000000000000759","article-title":"Matrix regeneration therapy: a case series of corneal neurotrophic ulcers","volume":"35","author":"Arvola","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2018.05.009_bib0155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/jop.2017.0010","article-title":"Neurotrophic keratopathy: therapeutic approach using a novel matrix regenerating agent","volume":"33","author":"Guerra","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2018.05.009_bib0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/ICO.0000000000001261","article-title":"Effect of a new matrix therapy agent in persistent epithelial defects after bacterial keratitis treated with topical fortified antibiotics","volume":"36","author":"Chappelet","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2018.05.009_bib0165","series-title":"Neuroparalytic Keratitis","first-page":"452","article-title":"Current ocular therapy","author":"Mackie","year":"1995"},{"key":"10.1016\/j.jfo.2018.05.009_bib0170","article-title":"Management of herpes zoster neurotropic ulcer using a new matrix therapy agent (RGTA): a case report","volume":"35","author":"De Monchy","year":"2012","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2018.05.009_bib0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12348-015-0048-x","article-title":"Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy","volume":"5","author":"Mateo","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2018.05.009_bib0180","article-title":"Ocular surface chemical injury treated by regenerating agent (RGTA Cacicol20)","volume":"7","author":"Ustaoglu","year":"2017","journal-title":"GMS Ophthalmol Cases"},{"key":"10.1016\/j.jfo.2018.05.009_bib0185","first-page":"465","article-title":"Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy","volume":"31","author":"Chebbi","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2018.05.009_bib0190","first-page":"243","article-title":"Amniotic membrane transplantation in the human eye","volume":"108","author":"Meller","year":"2011","journal-title":"Dtsch Arztebl Int"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551218304418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551218304418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:09:25Z","timestamp":1759259365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551218304418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0181551218304418"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2018.05.009","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}